KHAN NAJAT (CEO and President) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/19/2025ACC: 0002020969-25-000006
DirectorOfficer· CEO and President
Since Feb 2026
-17.58K
Net shares
Net seller
$72.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
17.58K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−17.58K
Price / share
$4.14
Trade value
$72.80K
% of position
2.3%
11/17/2025
753.12K→735.54K
Total
Net shares
−17.58K
Net value
-$72.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/17/2025 | F · Tax Withholding | −17.58K | $4.14 | $72.80K | 2.3% | 753.12K | 735.54K |
| Total | −17.58K | -$72.80K | ||||||
Derivative Transactions0
No derivative transactions reported